ZBH
53
3
GOOG
71
-4
EQR
31
-2
IVZ
46
-2
ROST
41
-19
DHR
50
-2
NWSA
71
-6
FSLR
50
10
HBI
49
-15
DE
46
-3
NKE
28
-3
EXPE
61
2
HPQ
57
-3
ABBV
55
2
GPC
44
-3
SIG
37
-3
INTC
16
-2
KMI
61
4
SE
88
5
GT
42
-3
ZBH
53
3
GOOG
71
-4
EQR
31
-2
IVZ
46
-2
ROST
41
-19
DHR
50
-2
NWSA
71
-6
FSLR
50
10
HBI
49
-15
DE
46
-3
NKE
28
-3
EXPE
61
2
HPQ
57
-3
ABBV
55
2
GPC
44
-3
SIG
37
-3
INTC
16
-2
KMI
61
4
SE
88
5
GT
42
-3
Financhill
Back

INmune Bio Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
37

INMB
INmune Bio

Last Price:
$7.30
Seasonality Move:
2.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

INmune Bio Stock Forecast

  • Over the next 52 weeks, INmune Bio has on average historically risen by 10.7% based on the past 6 years of stock performance.
  • INmune Bio has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is INmune Bio Stock Undervalued?
    The current INmune Bio [INMB] share price is $7.30. The Score for INMB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • INMB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will INmune Bio Stock Go Up Next Year?

  • Over the next 52 weeks, INmune Bio has on average historically risen by 10.7% based on the past 6 years of stock performance.

INmune Bio Stock Rating

Sell
37
INmune Bio (INMB) is a Sell

Is INmune Bio overpriced?

  • INmune Bio has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

INmune Bio Stock Price History

Is INMB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
inmunebio.com

52-Week Data

52-Week High:
10.50
52-Week Low:
4.32

Prediction Charts

Market Cap:
169.4M
Price in USD:
7.30
Volume:
305.8K
Beta:
1.89

Technical Analysis

SMA50:
7.63
SMA100:
7.65
SMA200:
6.68
52-Wk Change:
-27.87%

Stock Predictions

  • Is INmune Bio stock public?
    Yes, INmune Bio is a publicly traded company.
  • What is the INmune Bio stock quote today?
    The INmune Bio stock price is 7.30 USD today.
  • How to buy INmune Bio stock online?
    You can buy INmune Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 7.50 7.13 7.58 6.99
May-7 7.12 7.14 7.20 6.98
May-8 7.35 7.09 7.53 7.02
May-9 7.77 6.97 7.77 6.85
May-12 7.13 7.64 7.64 7.10
May-13 7.73 8.06 8.09 7.52
May-14 8.20 7.43 8.20 7.34
May-15 7.43 7.29 7.53 7.19
May-16 7.34 7.86 7.94 7.29
May-19 7.63 7.77 8.06 7.63
May-20 7.80 7.68 7.93 7.65
May-21 7.67 7.46 7.92 7.43
May-22 7.41 7.50 7.75 7.31
May-23 7.40 7.30 7.70 7.29

INmune Bio Earnings

INmune Bio Earnings Report: Per Share INmune Bio Earnings Q1 Q2 Q3 and Q4 last year and next year.

INmune Bio Forecast Revenue Growth

INmune Bio Stock Analysis: Historical quarterly revenues per share for INmune Bio and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.15 per share, an increase this year of $0.47 per share, and an increase next year of $0.07 per share.

* INmune Bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.